🔎 Trials Near Me

Gara Jalqabaatti › Luukemiya Mayiloomonositikii Keessummaa › Alabama › Birmingham

Qorannoo klinikaalii Luukemiya Mayiloomonositikii Keessummaa Birmingham, AL keessatti

Qorannoo 4 Luukemiya Mayiloomonositikii Keessummaa f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 2
  • The University of Alabama at Birmingham, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07249346

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Namoota walitti qabaa jiraQorannoo ilaalaa
  • AllerVie Clinical Research, Birmingham
  • O'Neal Comprehensive Cancer Center at the UAB, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07143669

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Namoota walitti qabaa jiraSadarkaa 2
  • University of Alabama Birmingham, Birmingham
Umuriin 18 hanga 66 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT06859424

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Kirklin Clinic of UAB Hospital, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2025 · NCT03850574

Qorannoo Luukemiya Mayiloomonositikii Keessummaa magaalota biroo keessatti

Qorannoo biroo Birmingham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.